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Introduction. Soft tissue tumors around the knee joint still pose problems for the excision and subsequent reconstruction.Methods.
In the 6 included patients the soft tissue sarcoma has its base on the anterior surface of the extensormechanism and expands towards
the skin.The entire extensor apparatus (quadriceps tendon, patella, and patellar tendon) was resected and replaced by a fresh-frozen
allograft. Results. Themean follow-up was 6.7 years (range: 2–12.4 years). In two patients a local recurrence occurred, resulting in a
5-year local recurrence-free rate of 66.7% (95% CI: 19.5%–90.4%). Distant metastases were found in 4 patients resulting in a 5-year
metastasis-free rate of 33.3% (95% CI: 4.6%–67.5%). Two patients underwent at least one revision surgery, including one patient
in whom the allograft had to be removed. According to the ISOLS function score 24.7 points (range: 19–28 points) were achieved
at the last follow-up. The mean active flexion of the knee joint was 82.5∘ (range: 25–120∘) and a mean extension lag of 10∘ (range:
0–30∘) was observed. Conclusions.The replacement of the extensor mechanism by an allograft is a reasonable option, allowing wide
margins and restoration of active extension inmost patients.Trial Registration.The presented study is listed on the ISRCTN registry
with trial number ISRCTN63060594.
1. Introduction
Soft tissue sarcomas represent a heterogeneous group of
lesions that are often subtle in presentation and have a wide
variation in extent of malignant behavior. Because of the
rarity and vast histological varieties, they frequently pose
diagnostic problems. The knee joint and the adjacent struc-
tures are quite uncommon locations for soft tissue sarcoma
[1]. The most common entities are liposarcoma (25%) and
synovial sarcoma (25%), followed by fibrosarcoma (9%) and
undifferentiated pleomorphic sarcoma (8%) [1].
Over the recent decades, limb-sparing surgery has
become an accepted method of treatment for most patients
with soft tissue sarcomas. Advances in surgical techniques,
prosthetic design, and bone allograft banking have opened
the avenue for reconstruction procedures after wide excision
of bone and soft tissues. This allows the surgeon to achieve
adequate margins while salvaging the limb and its function.
Yet, soft tissue tumors around the knee joint still pose
problems for the excision and subsequent reconstruction.
Extension of the tumor in the joint or in the extensor
mechanism is a challenging situation to achieve adequate
margins and a good functional limb. There is no current
consensus as to the best method of reconstruction of the
extensor mechanism of the knee [2]. Few reconstructive
options are available to avoid knee arthrodesis including
tendon transfers or local grafts [3], synthetic materials [4],
and allograft tissues [5]. Regardless of the used reconstruction
technique, the principal technical difficulty remains to be
restoration of the extensor function and the provision of soft
tissue coverage. In the current literature, no data is available
considering specifically the demanding situation of soft tissue
sarcomas involving the extensor mechanism of the knee.This
study aims to highlight the surgical difficulties as well as the
oncological and functional results after a resection of the
extensor apparatus due to a soft tissue sarcoma.
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Figure 1: Inclusion criteria of the patients according to the tumor
localization. Schematic illustration of a knee joint (lateral view).
The patients were divided into 2 groups according the tumor
localization. Patients with a superficially spreading lesion and no
joint involvement were included in this study (indicated as number
1). If the tumor site is deep and involves the joint space (indicated as
number 2) an extra-articular resection of the knee was performed.
2. Materials and Methods
2.1. Patients. Between 2002 and 2012 17 patients were treated
for a soft tissue sarcoma involving the knee extensor appa-
ratus in one institution. We observed mainly two different
extension and growth patterns of the tumor (see Figure 1):
11 patients showed an intra-articular expansion of the tumor
mass with contamination of the joint cavity, whereas in 6
patients the soft tissue sarcoma has its base on the anterior
surface of the extensor mechanism and expands towards the
skin. The 11 patients with involvement of the joint space
needed an extra-articular knee resection and an allograft
prosthetic composite reconstruction as formerly described
[6] and were therefore excluded from this study.
All patients (𝑛 = 6), who have undergone a surgical
resection of a soft tissue sarcoma affecting the quadriceps
tendon, the patella, and/or the patellar tendon without
apparent joint involvement were included in this study. The
tumors were adherent and fixed to the underlying extensor
mechanism.
These cases were oftenmisdiagnosed as a chronic inflam-
mation process of the prepatellar bursa prior to the referral
to our institution. Therefore, all the included patients under-
went an inadequate and intralesionally previous surgery
before our treatment. The presence of either microscopic
(R1) or macroscopic (R2) residual tumor was classified as
inadequate resection.The histological diagnosis was based on
the primary excision of the tumor. All the external his-
tology samples were ordered and reviewed by the institu-
tional pathology. The detailed characteristics of the included
patients are indicated in Table 1.
2.2. Surgical Technique. It must be assumed that tumor cells
were implanted in the surrounding tissue after the first
inadequate surgery outside. During the reexcision the whole
area which is theoretically contaminated should be removed.
In all the included cases the previous surgeries were small
with short incisions. The presented surgical technique was
only performed, if the whole previous surgical area could
be removed completely. If this was not possible, an extra-
articular resection or an above-knee amputation was consid-
ered.
Only in the patient who underwent an arthroscopy the
area of the possible iatrogenic spread of tumor cells was
difficult to define. As the tumor was outside the joint capsule
and not touched by the arthroscopy portals, we considered
a limb salvage procedure feasible. However, it is important
to bear in mind that a compartmental resection was not
achieved in this case with the presented technique. The only
remaining alternative surgical option would be an above-
knee amputation, which the patient refused categorically.
The crucial criterion for the surgical indication in the
presented patients was the absence of tumor involvement of
the joint cavity. All the presented patients had an MRI before
the initial surgery in the referral hospital.TheMRI before and
after the initial inadequate surgery were both available and
evaluated in our institution. If no effusion was found in the
clinical examination and all available MRI revealed no tumor
mass deep to the extensor mechanism, we resigned an extra-
articular knee resection. Instead, the whole extensor appara-
tus was resected in its entire length including distal part of
quadriceps tendon, patella, and patellar ligament through a
midline anterior approach (Figure 2).The quadriceps tendon
was spared as much as the tumor expansion allowed. In all
patients, a size-matched fresh-frozen nonirradiated allograft
harvested from donors younger than 40 years was used to
restore the extensor mechanism. The allograft consists of the
quadriceps tendon, the patella, the patellar tendon, and the
tibia tuberosity. First the allograft bone block of the tuberosity
was fixed to the host tibia by screws. Then the allograft
quadriceps tendon was sutured to the remaining host tendon
and to the medial and lateral edges of the quadriceps muscle
in full extension of the knee joint. This important tendon to
tendon suture was done bymodifiedMason Allen stitches [7]
with nonabsorbable fibers.
In 5 out of 6 patients, a free or rotational flap was nec-
essary for sufficient soft tissue coverage: a rotational medial
gastrocnemius flap was performed in one and a free fascio-
cutaneous flap (anterolateral thigh flap from the contralateral
limb) in 4 patients.
2.3. Surgical Aftercare and Follow-Up. The affected knee was
maintained in a plaster splint for 5weeks. After removal of the
splint, patients began active and passive mobilization assisted
by a physiotherapist. For the first 5 weeks, an ambulationwith
2 crutches and non-weight bearing was allowed. The weight
bearing was increased stepwise until full weight bearing was
usually achieved 3months after the surgery.The patients were
followedwith serial clinical and radiographic examinations of
the limb, combinedwith CT imaging of the chest. For the first
3months, clinical and radiographic follow-ups were obtained
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Figure 2: Surgical technique. Clinical case (patient number 4) as example for the surgical technique used in the described study population.
(a) Complete resection of lesion and extensor apparatus; (b) preparation of the osteotendinous allograft; (c) fixation of the allograft with
screws distally and direct end-to-end suture proximally; (d) postoperative radiography.
monthly. Afterwards the intervals were extended to 3 months
in the first 2 years, 4 months in the 3rd year, 6 months in the
4th, 5th, and 6th years, and finally once a year until the 10th
year after the surgery.
2.4. Oncological Treatment. The indication and the sequence
of adjuvant therapies such as chemotherapy or irradiation
were discussed in a multidisciplinary sarcoma board. Com-
pared to other soft tissue sarcomas, synovial sarcomas are
relatively chemosensitive [8]. For this reason, both patients
diagnosed with synovial sarcoma received a systemic treat-
ment with doxorubicin and ifosfamide. Patient number 3 had
a high grade pleomorphic sarcoma with a high probability
of developing metastatic disease. The interdisciplinary board
decided to apply a preoperative “prophylactic” chemotherapy
and radiation therapy. In patient numbers 1 and 2 the surgical
margins were either marginal or tumor-free but “close.”
These two patients received a postoperative radiation therapy
to improve local control.
2.5. Measurements and Statistical Analysis. As indicators for
the knee function the active range of motion, active flexion,
and extension lag were measured and the International
Society of Limb Salvage (ISOLS) score was calculated [4] at
the last follow-up.
Survival curves were generated using the Kaplan-Meier
method. Statistical analyses were done by the help of the
software Stata version 12.1 (Statacorp, College Station TX,
USA). 𝑃 values < 0.05 were considered significant.
3. Results and Discussion
3.1. Results. Themean follow-up was 6.7 years (range: 2–12.4
years). An overview considering the complications of the
treatment and oncological outcome is highlighted in Table 2.
3.1.1. Complications. In 2 patients, at least one revision
surgery was necessary including 1 patient in whom the allo-
graft had to be removed: Patient number 1 fell on the operated
knee 12 years after the surgery and suffered consecutively
from an extension deficit. A rupture of the quadriceps tendon
was identified at the musculotendinous transition zone. The
ruptured tendon was replaced by a new allograft of the
extensor apparatus and reinforced by an artificial ligament.
The second casewhoneeded a surgical revision (patient num-
ber 6) showed a partial necrosis of the primary flap during
the first twoweeks postoperatively. A secondary coverage was
achieved by skin transplantation harvested from the inguinal
region.
In one case (patient number 2) a traumatic fracture of
the allograft happened 6 years after the surgery, affecting the
tibia tuberosity. As the fracture showed no displacement and
the integrity of the extensor mechanism was not disturbed,
conservative treatment achieved complete healing of the
bone.
3.1.2. Functional Results. The different functional outcomes
for every patient are indicated in Table 3. On average 24.7
points (range: 19–28 points) were achieved using the ISOLS
score. The mean active flexion of the knee joint was 82.5∘
(range: 25–120∘). Patients were suffering from a mean exten-
sion lag of 10∘ (0–30∘). Due to this lag, the range of motion
averaged with 72.5∘ (range: 25–100∘) lower than the flexion
alone. No obvious correlation between the preoperative (all
the patients had a ROM of at least 90∘ and more before the
surgery in our institution) and the postoperative functionwas
found. The poor ROM of patient number 6 was due to the
difficult soft tissue situation. The primary flap was necrotic
and a revision surgery was performed. A complete closure of
the surgical field was achieved, but the flexion was restricted
because of scar tissue and adhesions.
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Table 2: Oncological results and complications.
Patient
number
Follow-up
(months)
Oncological
result
Local recurrence
(months)
Metastasis
(months) Complications
1 149 CDF None None Rupture of quadriceps tendon
2 145 NED 27 None Fracture of tibia tuberosity
3 62 DOD None 15 None
4 22 DOD 16 17 None
5 76 AWD None 6 None
6 28 AWD None 6 Partial necrosis of flap
CDF: continuously disease-free; DOD: dead of disease; AWD: alive with disease; NED: no evidence of disease.
Table 3: Functional results.
Patient
number
Follow-up
(months)
ISOLS score
(points)
Active ROM
(degree ∘)
Active Flexion
(degree ∘)
Extension Lag
(degree ∘)
1 149 28 60 90 30
2 145 19 90 100 10
3 62 28 100 120 20
4 22 23 60 60 0
5 76 24 100 100 0
6 28 26 25 25 0
ROM: range of motion.
3.1.3. Oncological Results. At the last follow-up one patient
was disease-free, 2 patients were alive with disease and 2
patients died because of the disease. In one patient no evi-
dence of disease was found after treating a local recurrence.
The disease specific 5-year survival of the patients was 62.5%
(95% CI: 21.3–89.3%).
The histological examination of the resected tumor
revealed 5 wide surgical margins and one case with marginal
margins. In all patients, residual tumor cells were found in the
reexcision samples. Especially in the deep surface against the
extensor mechanism the margins were all inadequate, prob-
ably because the previous surgeons were afraid to injure the
patellar ligament.
The patient with marginal margins had a local recurrence
after 16 months. Furthermore, one local recurrence occurred
after an adequate surgery with wide margins. As shown
in Figure 3 the 5-year local recurrence-free rate is 66.7%
(95% CI: 19.5%–90.4%). Distant metastases were found in
4 patients resulting in a 5-year metastasis-free rate of 33.3%
(95% CI: 4.6%–67.5%).
The effect of the applied radiotherapy for local control and
the chemotherapy for systemic disease was not measurable as
the numbers are too small and the histologic types of the
sarcomas are too heterogeneous. The radiation therapy was
applied as planned with the favored dose in all 3 patients
concerned. As the tumors were all superficial, skin reactions
were common. But no complication due to the radiation
therapy was observed.
3.2. Discussion. A soft tissue sarcoma of the extensor mech-
anism poses a particularly demanding surgical situation.The
oncologic surgeon does handle the difficulties not only to
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Figure 3: Local recurrence-free survival curve. Kaplan-Meier curve
for local recurrence-free survival.
achieve adequate margins in a surgical field of sparse soft tis-
sue coverage, but also to reconstruct the extensor mechanism
providing good functional results.
The aimof the studywas to evaluate the (1) complications,
(2) functional outcome, and (3) oncological results in patients
suffering from a soft tissue sarcoma of the knee extensor
mechanism with absence of joint invasion.
3.2.1. Limitations. Our presented case series has some limita-
tions. First, as with other series dealing with reconstruction
of the knee extensor mechanism, the number of included
patients is small, although relatively large compared to the
available studies in the literature. Second, our series of tumors
was heterogeneous for type, stage, and adjuvant treatment.
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These variables certainly affect rates of survival but not
whether adequatemargins or restored functionwas achieved.
Third, different procedures for soft tissue coverage were
performed, according to the case-specific situation.
3.2.2. Reconstruction Technique. The use of an allograft
extensor mechanism proved to be a valid strategy for the
reconstruction. The presented technique is mainly for pri-
mary tumors without any previous surgery. These are the
preferred conditions for an oncological correct resection
providing the best local control. Experience in using an
allograft extensor mechanism in the tumor setting is lacking
completely in literature. Although in a nononcological setting
(major revision in total knee arthroplasties), previous reports
confirm the safety and functionality of the reconstructive
procedure [2, 9–12]. Our functional results regarding active
range of motion, active flexion, and extension lag are consis-
tent with these series [2, 9, 10, 12]. There is only one existing
case study which can be compared to our results. Imanishi
et al. described 4 cases [5] in whom the patellar tendon was
resected due to a soft tissue sarcoma. The patellar tendon
was reconstructed with a bone-tendon-bone allograft and
fixed by wires and screws to the residual patella and tibia
tuberosity. This technique presupposes the preservation of
the quadriceps tendon together with some residual patella.
In all our patients this would have led to inadequate excision
of the tumor. The functional results were excellent in the
series of Imanishi et al. [5] as all patients achieved virtually
full range of motion and 28–30 points in the MSTS score.
The difference to our results probably lies in the extent of
the resection. All of our patients had to undergo a complete
resection of the previous surgical area. In addition to the
defect of the extensor mechanism, large soft tissue defects
resulted. The need of extensive resections certainly has a
negative influence on the functional outcome.
Different alternative reconstructions were previously
described in the oncologic setting. As substitute for the
patellar tendon a fascia lata graft [3, 13], autologous achilles
tendon [14], or hamstring tendon grafts [15, 16], as well
as a latissimus dorsi flap [17], were proposed. In contrast
to all these case reports Muramatsu et al. [18] described
a complete resection of the extensor apparatus including
quadriceps tendon, patella, and patellar tendon.After treating
the resected specimen with liquid nitrogen intraoperatively,
the extensor mechanism was reimplanted as recycled auto-
graft. We have some reservations concerning this recycled
autograft technique, as in our opinion the oncologic safety is
questionable.
3.2.3. Complication Rate. In our presented reconstruction
technique, the short- and long-term morbidity rates were
acceptable for tumors, which widely involved the knee. No
deep infection was observed. Possible explanation is the use
of an aggressive perioperative antibiotic prophylaxis. Two
of the three complications were attributed to the allograft:
one allograft fracture and one rupture of the quadriceps
tendon. The fracture was treated conservatively, meaning
that a total of one allograft (16.7%) needed to be surgically
revised. This is slightly higher than previous reported case
in revision surgeries of failed extensor mechanism due to
total knee arthroplasties [19]. Fracture and rupture of the
allograft both occurred late in clinical course and had clear
traumatic reason. Assuming the healing was complete after
this time, the complications are hardly attributable to the
reconstruction technique. Nevertheless, Imanishi et al. [5]
observed a fracture of the allograft, too. So, the structural
weakness of the allograft substitute seems to be the major
reason for failure.
3.2.4. Oncologic Outcome. The residual tumor and the whole
area of the previous surgery were removed in one piece allow-
ing a reliable histological work-up. In all the included patients
an above-knee amputation was a valid option. In general, the
safety of tumor removal must always be weighed against the
remaining limb function. In all the presented patients we
decided against an amputation after a comprehensive discus-
sion.
However, it is not clear whether amputation would have
improved the oncological result. The metastatic rate cannot
be influenced by local measures and depends mainly on size
and histologic grading of the tumor [20]. Regarding the local
recurrence current studies showed that the outcome is worse
if an unplanned excision in a nononcological settingwas done
prior to the referral in a tertiary sarcoma center, independent
of the anatomical location [21–23].
The oncological outcome is difficult to compare with
other series in the literature as no specific results for the
extensor mechanism are available and the prognostic among
soft tissue sarcomas varies widely according to histologic
type, grade size, and location [24–27]. Local recurrence rates
after radiation and resection have been reported as high as
20% [28]; howevermost recent series report number at 10%or
less [24, 25, 29]. In overall, our local recurrence rate seems to
be much higher compared to other localizations. All patients
have undergone an inadequate previous surgery before the
referral to our tertiary care center. Because of the superficial
location of the lesions and the proximity to the prepatellar
bursa, they were all misdiagnosed as benign tumors or
chronic bursitis. An unplanned excision of soft tissue sar-
comas or an inadequate biopsy is associated with a poor
local control [21–23]. At least in our series, unplanned
resections of soft tissue sarcomas before a correct diagnosis
seem to pose a serious problem around the knee joint. One
patient had even undergone an arthroscopy before the sar-
coma diagnosis. Although the arthroscopic procedure was
independent of the tumor excision, there is still the risk of
wide spreading of tumor cells through the used liquid. At the
time of the reexcision in our institution no evidence for joint
involvementwas found but the decision for a joint-preserving
resection remains debatable in this situation. Unfortunately,
a local recurrence occurred indeed, and the patient died from
the disease due to systemic metastasis.
A recent published case study reported similar oncologic
problems: 3 out 4 patients included in their series had an
unplanned excision of a sarcoma affecting the patellar tendon
[5]. But, the present case series is inhomogeneous with
respect to former surgery and the potential contamination
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status before the index operation in our institution.This may
additionally cause the bias of high local recurrence rates.
4. Conclusions
In summary, the treatment of soft tissue sarcoma involving
the extensor apparatus of the knee is associated with a high
rate of previous inadequate surgeries and high local recur-
rence and metastatic rates. The replacement of the extensor
mechanism by an allograft is a reasonable option, allowing
wide margins and restoration of active extension in most
patients.
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